Oxidative stress cytotoxicity induced by platinum-doped magnesia nanoparticles in cancer cells
Mohamed Qasim Al-Fahdawi, Faris A. J. Al-Doghachi, Qasim Khlaif Abdullah, Ruaa Tareq Hammad, Abdullah Rasedee, Wisam Nabeel Ibrahim, Hussah Abdullah Alshwyeh, Areej A. Alosaimi, Sahar Khamees Aldosary, Eltayeb E. M. Eid, Rozita Rosli, Yun Hin Taufiq‐Yap, Nagi Ahmed Abdullah Al-Haj, Mothanna Al-Qubaisi
Abstract
The aim of this study was to prepare, characterize, and determine the in vitro anticancer effects of platinum-doped magnesia (Pt/MgO) nanoparticles. The chemical compositions, functional groups, and size of nanoparticles were determined using X-ray diffraction, Fourier transform infrared spectroscopy, energy dispersive X-ray spectroscopy, transmission electron microscopy, and scanning electron microscopy. Pt/MgO nanoparticles were cuboid and in the nanosize range of 30-50 nm. The cytotoxicity of Pt/MgO nanoparticles was determined via the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay on the human lung and colonic cancer cells (A549 and HT29 respectively) and normal human lung and colonic fibroblasts cells (MRC-5 and CCD-18Co repectively). The Pt/MgO nanoparticles were relatively innocuous to normal cells. Pt/MgO nanoparticles downregulated Bcl-2 and upregulated Bax and p53 tumor suppressor proteins in the cancer cells. Pt/MgO nanoparticles also induced production of reactive oxygen species, decreased cellular glutathione level, and increased lipid peroxidation. Thus, the anticancer effects of Pt/MgO nanoparticles were attributed to the induction of oxidative stress and apoptosis. The study showed the potential of Pt/MgO nanoparticles as an anti-cancer compound.